Abstract
The NF-kB family consists of a group of inducible transcription factors which regulate immune and inflammatory responses and protect cells from undergoing apoptosis in response to cellular stress. A number of signal transduction cascades can activate the NF-kB pathway to result in the translocation of the NF-kB proteins from the cytoplasm to the nucleus where they activate the expression of specific cellular genes. In this review, we discuss cellular genes which are regulated by NF-kB and disease states which are associated with constitutive activation of the NF-kB pathway. Strategies to prevent prolonged activation of the NF-kB pathway are also discussed.
Keywords: NF-kB, Pathogenesis, apoptosis, NF-kB proteins, including interleukin 1b (IL-1b), tumor necrosis factor(TNFa), nitric oxide synthase(iNOS), oxide (NO), cyclo-oxygenase (COX-2), (cIAP1, cIAP2, IXAP)
Current Molecular Medicine
Title: Role of the NF-kB Pathway in the Pathogenesis of Human Disease States
Volume: 1 Issue: 3
Author(s): Yumi Yamamoto and Richard B. Gaynor
Affiliation:
Keywords: NF-kB, Pathogenesis, apoptosis, NF-kB proteins, including interleukin 1b (IL-1b), tumor necrosis factor(TNFa), nitric oxide synthase(iNOS), oxide (NO), cyclo-oxygenase (COX-2), (cIAP1, cIAP2, IXAP)
Abstract: The NF-kB family consists of a group of inducible transcription factors which regulate immune and inflammatory responses and protect cells from undergoing apoptosis in response to cellular stress. A number of signal transduction cascades can activate the NF-kB pathway to result in the translocation of the NF-kB proteins from the cytoplasm to the nucleus where they activate the expression of specific cellular genes. In this review, we discuss cellular genes which are regulated by NF-kB and disease states which are associated with constitutive activation of the NF-kB pathway. Strategies to prevent prolonged activation of the NF-kB pathway are also discussed.
Export Options
About this article
Cite this article as:
Yamamoto Yumi and Gaynor B. Richard, Role of the NF-kB Pathway in the Pathogenesis of Human Disease States, Current Molecular Medicine 2001; 1 (3) . https://dx.doi.org/10.2174/1566524013363816
DOI https://dx.doi.org/10.2174/1566524013363816 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery (Discontinued) A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin – Molecular Mechanisms
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on DNA & Gene Sequences Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioinformatics-based Identification of Proteins Expressed by Arthropod- borne Viruses Transmitted by <i>Aedes Aegypti</i> Mosquito
Current Proteomics Synthesis of Some Novel Substituted Phenyl β, β-Diphenyl Propanoate with Analgesic and Anti-inflammatory Activity
Current Bioactive Compounds Neonatal Fever in the Term Infant: Evaluation and Management Strategies
Current Pediatric Reviews Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
Current Neuropharmacology Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry Determinants of Anti-Cancer Effect of Mitochondrial Electron Transport Chain Inhibitors: Bioenergetic Profile and Metabolic Flexibility of Cancer Cells
Current Pharmaceutical Design Inflammation Fueling Atrial Fibrillation Substrate: Seeking Ways to "Cool" the Heart
Medicinal Chemistry Quinoline Fused 2-Azetidinone Derivatives bearing Dihyropyrimidinone: Benign Synthesis and its Pharmacological Assessment
Current Bioactive Compounds Immunomodulatory Effects of Macrolides in the Lung: Lessons from In- Vitro and In-Vivo Models
Current Pharmaceutical Design Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula
Current Bioinformatics Myocardial Structure and Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Cell Reprogramming: A New Chemical Approach to Stem Cell Biology and Tissue Regeneration
Current Pharmaceutical Biotechnology Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
Current Medicinal Chemistry Association of Selected Adipocytokines and Inflammatory Markers on Body Mass Index in Type 2 Diabetes Patients in Saudi Arabia and as Risk Factors to Cardiovascular Disease
Current Diabetes Reviews Development of an Insect Cell-Free System
Current Pharmaceutical Biotechnology Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease
Current Medicinal Chemistry